These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23574969)

  • 1. Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study.
    Padfield GJ; Din JN; Koushiappi E; Mills NL; Robinson SD; Cruden Nle M; Lucking AJ; Chia S; Harding SA; Newby DE
    Heart; 2013 Sep; 99(18):1330-5. PubMed ID: 23574969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor-α antagonism: a potential therapeutic target for prevention of arrhythmogenesis in the setting of acute myocardial infarction?
    Padfield GJ
    Heart; 2014 Feb; 100(3):264. PubMed ID: 24014281
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.
    Fichtlscherer S; Rössig L; Breuer S; Vasa M; Dimmeler S; Zeiher AM
    Circulation; 2001 Dec; 104(25):3023-5. PubMed ID: 11748093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers.
    Din JN; Archer RM; Harding SA; Sarma J; Lyall K; Flapan AD; Newby DE
    Heart; 2013 Feb; 99(3):168-74. PubMed ID: 23184014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-α is a foe for patients with acute myocardial infarction.
    Padfield GJ
    Heart; 2014 Jan; 100(2):181. PubMed ID: 24041651
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour necrosis factor-α is a foe for patients with acute myocardial infarction.
    Shi KH; Tao H; Wu JX
    Heart; 2014 Jan; 100(2):180-1. PubMed ID: 24006451
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour necrosis factor-α antagonism: a potential therapeutic target for prevention of arrhythmogenesis in the setting of acute myocardial infarction?
    Yalta K; Sivri N; Geyik B; Yetkin E
    Heart; 2014 Feb; 100(3):263. PubMed ID: 24006454
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
    Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
    Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.
    Gao C; Liu Y; Yu Q; Yang Q; Li B; Sun L; Yan W; Cai X; Gao E; Xiong L; Wang H; Tao L
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1583-91. PubMed ID: 25888509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue necrosis factor α and targeting its receptor in ischaemic heart disease.
    Moliterno DJ; Smyth SS
    Heart; 2013 Sep; 99(18):1305-6. PubMed ID: 23697653
    [No Abstract]   [Full Text] [Related]  

  • 12. Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation.
    Chia S; Wilson R; Ludlam CA; Webb DJ; Flapan AD; Newby DE
    Clin Sci (Lond); 2005 Jan; 108(1):65-72. PubMed ID: 15367100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation.
    Zanni MV; Stanley TL; Makimura H; Chen CY; Grinspoon SK
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):48-54. PubMed ID: 19878508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
    Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
    J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled, trial of transforaminal epidural etanercept for the treatment of symptomatic lumbar disc herniation.
    Freeman BJ; Ludbrook GL; Hall S; Cousins M; Mitchell B; Jaros M; Wyand M; Gorman JR
    Spine (Phila Pa 1976); 2013 Nov; 38(23):1986-94. PubMed ID: 24165696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.
    Jobe LJ; Meléndez GC; Levick SP; Du Y; Brower GL; Janicki JS
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1462-8. PubMed ID: 19666842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.
    Lo J; Bernstein LE; Canavan B; Torriani M; Jackson MB; Ahima RS; Grinspoon SK
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E102-9. PubMed ID: 17374698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
    Moutsopoulos NM; Katsifis GE; Angelov N; Leakan RA; Sankar V; Pillemer S; Wahl SM
    Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sildenafil citrate and etanercept treatment on TNF-α levels in peripheral blood of women with recurrent miscarriage.
    Ohams M; Jerzak M; Górski A
    Ginekol Pol; 2015 Jul; 86(7):520-4. PubMed ID: 26376530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis alpha-blocking agent (etanercept): a triple blind randomized controlled trial of its use in treatment of sciatica.
    Okoro T; Tafazal SI; Longworth S; Sell PJ
    J Spinal Disord Tech; 2010 Feb; 23(1):74-7. PubMed ID: 20072036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.